Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,240 public trials 379 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917

Conditions
Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • START Los Angeles Los Angeles, California, United States
  • Skin Cancer Institute Englewood, Colorado, United States
  • Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 20 locations
View Trial Details
Recruiting

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

NCT07519655

Conditions
Cutaneous Melanoma, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations
  • Presbyterian/St Lukes Medical Center Denver, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Sarah Cannon Research Institute- Pharmacy Nashville, Tennessee, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT04913285

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • The Angeles Clinic Los Angeles, California, United States
  • UCLA Los Angeles, California, United States
  • University of California San Diego, Moores Cancer Center San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 48 locations
View Trial Details
Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

NCT07070232

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +25 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Hartford Healthcare Hartford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 76 locations
View Trial Details
Recruiting

Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination With Pembrolizumab, in Unresectable Melanoma Patients

NCT06284590

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • Universitätsklinikum Essen Essen, Germany
  • University of Freiburg, Faculty of Medicine Freiburg im Breisgau, Germany
View Trial Details
Recruiting

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

NCT05896839

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +34 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 26 locations
View Trial Details

Related conditions